Pfizer

Pfizer Inc.
	Logo used since 2021
Company type	Public
Traded as	NYSE: PFE; S&P 100 component; S&P 500 component;
Industry	Pharmaceutical; Biotechnology;
Founded	1849; 175 years ago in New York City
Founders	Charles Pfizer; Charles F. Erhart;
Headquarters	The Spiral, New York City, US
Area served	Worldwide
Key people	Albert Bourla; (Chairman and CEO)
Products	Pharmaceutical drugs; vaccines;
Revenue	US$58.5 billion (2023)
Operating income	$2.17 billion (2023)
Net income	$2.12 billion (2023)
Total assets	$226.5 billion (2023)
Total equity	$89.01 billion (2023)
Number of employees	c. 88,000 (2023)
Website	www.pfizer.com
	Footnotes / references;

Former corporate logos (until 2021).

Pfizer Inc. (/ˈfaɪzər/ FY-zər)^[3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849, in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in 2023 revenues), a pneumococcal conjugate vaccine ($6 billion in 2023 revenues), palbociclib ($4 billion in 2023 revenues), and tafamidis ($3 billion in 2023 revenues).^[1] In 2023, 46% of the company's revenues came from the United States, 6% came from Japan, and 48% came from other countries.^[1]

As of 2024, the company ranks 69th on the Fortune 500.^[4]